AP3138A - Production of encapsulated nanoparticles at high volume fractions - Google Patents

Production of encapsulated nanoparticles at high volume fractions

Info

Publication number
AP3138A
AP3138A AP2011005993A AP2011005993A AP3138A AP 3138 A AP3138 A AP 3138A AP 2011005993 A AP2011005993 A AP 2011005993A AP 2011005993 A AP2011005993 A AP 2011005993A AP 3138 A AP3138 A AP 3138A
Authority
AP
ARIPO
Prior art keywords
production
high volume
volume fractions
encapsulated nanoparticles
nanoparticles
Prior art date
Application number
AP2011005993A
Other languages
English (en)
Other versions
AP2011005993A0 (en
Inventor
Marck Norret
Aaron Dodd
Adrian Russell
Original Assignee
Iceutica Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901744A external-priority patent/AU2009901744A0/en
Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd
Publication of AP2011005993A0 publication Critical patent/AP2011005993A0/xx
Application granted granted Critical
Publication of AP3138A publication Critical patent/AP3138A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/18Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B02CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02CCRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/14Mills in which the charge to be ground is turned over by movements of the container other than by rotating, e.g. by swinging, vibrating, tilting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B02CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02CCRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/18Details
    • B02C17/20Disintegrating members

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AP2011005993A 2009-04-24 2010-04-23 Production of encapsulated nanoparticles at high volume fractions AP3138A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17227809P 2009-04-24 2009-04-24
AU2009901744A AU2009901744A0 (en) 2009-04-24 Production of Encapsulated Nanoparticles at High Volume Fractions
PCT/AU2010/000464 WO2010121320A1 (en) 2009-04-24 2010-04-23 Production of encapsulated nanoparticles at high volume fractions

Publications (2)

Publication Number Publication Date
AP2011005993A0 AP2011005993A0 (en) 2011-12-31
AP3138A true AP3138A (en) 2015-02-28

Family

ID=43010603

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005993A AP3138A (en) 2009-04-24 2010-04-23 Production of encapsulated nanoparticles at high volume fractions

Country Status (21)

Country Link
US (6) US20120165410A1 (he)
EP (2) EP2421509B1 (he)
JP (2) JP6141012B2 (he)
KR (3) KR101743896B1 (he)
CN (2) CN105663045A (he)
AP (1) AP3138A (he)
AU (1) AU2010239159C1 (he)
BR (1) BRPI1014878A2 (he)
CA (1) CA2759102A1 (he)
CO (1) CO6470805A2 (he)
DK (1) DK2421509T3 (he)
EA (1) EA201171279A1 (he)
IL (2) IL254370B2 (he)
MA (1) MA33297B1 (he)
MX (1) MX356518B (he)
MY (1) MY159098A (he)
NZ (1) NZ595973A (he)
SG (1) SG175309A1 (he)
UA (1) UA110322C2 (he)
WO (1) WO2010121320A1 (he)
ZA (1) ZA201108651B (he)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008000042A1 (en) 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
UA106231C2 (uk) 2009-04-24 2014-08-11 Айсьютика Пти Лтд Разова доза фармацевтичної композиції індометацину (варіанти)
AU2010239161B2 (en) * 2009-04-24 2014-10-09 Iceutica Pty Ltd Production of encapsulated nanoparticles at commercial scale
EA201171284A1 (ru) * 2009-04-24 2012-05-30 Айсьютика Пти Лтд. Новая технология изготовления напроксена
NZ595902A (en) * 2009-04-24 2014-10-31 Iceutica Pty Ltd Method for the production of commercial nanoparticle and microparticle powders
EP2421530B1 (en) * 2009-04-24 2019-08-21 Iceutica Pty Ltd. Formulation of metaxalone
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
LT2568988T (lt) * 2010-05-11 2016-09-12 Janssen Pharmaceutica, N.V. Farmacinės kompozicijos, apimančios 1-(beta-d-gliukopiranozil)-2-tienilmetilbenzeno darinius kaip sglt inhibitorius
AU2012241897C1 (en) 2011-04-13 2017-05-11 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
EP2712628B1 (en) 2012-09-28 2016-08-10 Shanta Banerjee Composition for use as a medicine or dietetic food, in particular in the prevention and/or treatment of Diabetes and diabetes associated diseases
CN105121023B (zh) * 2013-02-28 2017-08-25 太阳化学公司 用于在液体分散液中制造研磨的固体的装置和连续方法
CA2918908A1 (en) * 2013-07-22 2015-01-29 Iceutica Inc. Formulation of metaxalone
US20150157646A1 (en) 2013-09-27 2015-06-11 Iceutica Inc. Abiraterone Steroid Formulation
ES2542088B1 (es) * 2014-01-29 2016-05-05 Enoc Solutions, S.L. Composición de azufre liposomado
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
CN104174468B (zh) * 2014-08-27 2016-06-15 上海延安药业有限公司 粘稠性药物锆珠研磨方法
CN107820483B (zh) * 2015-05-20 2020-08-18 皮埃尔和玛利居里大学(巴黎第六大学) 用于生产bp、b12p2及其混合物,特别是纳米粉末的机械化学方法
EP3804698B1 (en) 2015-08-03 2024-01-31 Tolmar International Limited Liquid polymer delivery system for extended administration of drugs
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US9975255B1 (en) * 2016-12-15 2018-05-22 Jabil Inc. Apparatus, system and method for providing a conformable vacuum cup for an end effector
CN107417640B (zh) * 2017-02-22 2019-03-26 浙江大学 纳米噻唑锌的制备方法
CN107198677B (zh) * 2017-05-25 2021-07-09 长春金赛药业有限责任公司 黄体酮混悬型长效注射剂及其制备方法和黄体酮混悬注射粉针
KR102105872B1 (ko) * 2018-05-18 2020-04-29 강원대학교산학협력단 열용융압출법을 이용하여 제조된 구리 나노콜로이드 분산체 및 이의 용도
EP3807287B1 (en) 2018-06-15 2025-07-30 Liliana Patricia RAMIREZ RIOS Metal complexes of beta-diketones and/or polyphenols by green chemistry, preparation method thereof, sunscreen thereof, skin or hair tone concealer thereof, hair dyeing thereof and other uses thereof
CN108902480A (zh) * 2018-07-27 2018-11-30 河南大华生物技术有限公司 一种提高饲料中微量添加物均匀度和生物利用度的方法
CN108904506A (zh) * 2018-07-27 2018-11-30 河南大华生物技术有限公司 一种地克珠利纳米粉末及其制备方法
UY38386A (es) * 2018-09-25 2020-04-30 Tolmar Int Ltd Sistema de suministro de polímero líquido para la administración prolongada de fármacos
KR102359021B1 (ko) * 2019-07-29 2022-02-07 (주)케나프 가용성 플라보노이드 및 폴리페놀의 함량을 증진시키는 케나프 종자의 가공방법 및 이의 가공물
CN113133970A (zh) 2020-01-17 2021-07-20 美国琛蓝营养制品股份有限公司 一种姜黄素复合物及其制备方法和检测方法
CN112674302A (zh) * 2021-01-07 2021-04-20 贵州山珍宝绿色科技开发有限公司 一种百香果刺梨果糕的制备方法
MX2023010120A (es) * 2021-03-03 2023-10-30 Pulmatrix Operating Co Inc Formulaciones de polvo seco de dihidroergotamina y metodos de uso.
CN113729011A (zh) * 2021-07-30 2021-12-03 安徽瑞然生物药肥科技有限公司 草甘膦可溶粒剂及其生产方法
JP2024178478A (ja) * 2021-11-04 2024-12-25 興和株式会社 医薬品
JP2024178477A (ja) * 2021-11-04 2024-12-25 興和株式会社 カプセル剤
US20250352543A1 (en) * 2021-11-16 2025-11-20 Beijing Tide Pharmaceutical Co., Ltd. Nanocrystalline preparation of rock2 inhibitor and preparation method therefor
CN114210995B (zh) * 2021-12-17 2023-03-10 浙江大学 一种利用牛蒡根提取液制备纳米银颗粒的方法、产品和应用
EP4209212A1 (en) * 2022-01-05 2023-07-12 HWI pharma services GmbH Aqueous composition comprising avermectins
CN114671704B (zh) * 2022-04-22 2023-04-18 广州粤瓷新材料有限公司 一种低膨胀多孔堇青石及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248813A (en) * 1992-11-25 1995-06-27 Eastman Kodak Co Polymeric grinding media used in grinding pharmaceutical substances
US5478705A (en) 1994-05-25 1995-12-26 Eastman Kodak Company Milling a compound useful in imaging elements using polymeric milling media
US5500331A (en) 1994-05-25 1996-03-19 Eastman Kodak Company Comminution with small particle milling media
JP4117811B2 (ja) * 1997-04-22 2008-07-16 日本化薬株式会社 フルタミド製剤及びその製法
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
ES2303527T3 (es) * 2000-05-10 2008-08-16 Jagotec Ag Procedimiento de molienda.
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
PT2283817T (pt) 2000-11-30 2016-08-22 Vectura Ltd Método de fabrico de partículas para utilização numa composição farmacêutica
JP2004099442A (ja) * 2002-09-04 2004-04-02 Nisshin Pharma Inc 難溶性薬物含有製剤およびその製造方法
KR20060024927A (ko) * 2004-09-15 2006-03-20 씨제이 주식회사 기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법
WO2006069419A1 (en) * 2004-12-31 2006-07-06 Iceutica Pty Ltd Nanoparticle composition and methods for synthesis thereof
RU2007133652A (ru) 2005-02-08 2009-03-20 Шугар Стил Инджиниринг Пти Лтд (Au) Способ и устройство для формирования металлической арматуры
JP2009519972A (ja) * 2005-12-15 2009-05-21 アキュスフィア, インコーポレイテッド 粒子ベースの経肺投与または経鼻投与用製薬の製造方法
JP2007169226A (ja) 2005-12-22 2007-07-05 Ono Pharmaceut Co Ltd 固体分散体
US8420122B2 (en) * 2006-04-28 2013-04-16 Merck Sharp & Dohme Corp. Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
NZ573823A (en) * 2006-06-30 2012-05-25 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
WO2008000042A1 (en) * 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
AR065802A1 (es) 2007-03-22 2009-07-01 Schering Corp Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
US8568696B2 (en) * 2008-08-06 2013-10-29 Indiana Nanotech Llc Grinding method for the manipulation or preservation of calcium phosphate hybrid properties
KR101679522B1 (ko) * 2009-04-24 2016-11-24 아이슈티카 피티와이 리미티드 생물학적 활성 물질의 용해 프로파일 개선방법
AU2010239161B2 (en) * 2009-04-24 2014-10-09 Iceutica Pty Ltd Production of encapsulated nanoparticles at commercial scale

Also Published As

Publication number Publication date
AU2010239159C1 (en) 2014-10-16
NZ595973A (en) 2014-02-28
JP6534689B2 (ja) 2019-06-26
KR101743896B1 (ko) 2017-06-05
SG175309A1 (en) 2011-11-28
MY159098A (en) 2016-12-15
US20240390871A1 (en) 2024-11-28
EA201171279A1 (ru) 2012-05-30
US20150306556A1 (en) 2015-10-29
CN105663045A (zh) 2016-06-15
KR101848766B1 (ko) 2018-05-28
US20170320030A1 (en) 2017-11-09
CO6470805A2 (es) 2012-06-29
CA2759102A1 (en) 2010-10-28
KR20120030384A (ko) 2012-03-28
ZA201108651B (en) 2013-01-30
JP2012524716A (ja) 2012-10-18
EP2421509A4 (en) 2013-01-09
WO2010121320A1 (en) 2010-10-28
AU2010239159B2 (en) 2014-06-12
EP2421509B1 (en) 2017-11-22
MX356518B (es) 2018-05-31
JP6141012B2 (ja) 2017-06-07
UA110322C2 (uk) 2015-12-25
AP2011005993A0 (en) 2011-12-31
JP2017101045A (ja) 2017-06-08
BRPI1014878A2 (pt) 2016-05-03
AU2010239159A1 (en) 2011-11-10
IL254370A0 (he) 2017-11-30
EP3338766A1 (en) 2018-06-27
IL254370B1 (he) 2023-08-01
KR20150032759A (ko) 2015-03-27
MX2011011230A (es) 2012-02-08
US20200316546A1 (en) 2020-10-08
IL254370B2 (he) 2023-12-01
MA33297B1 (fr) 2012-05-02
EP2421509A1 (en) 2012-02-29
IL215867A0 (en) 2012-01-31
US20180243707A1 (en) 2018-08-30
KR20160138326A (ko) 2016-12-02
DK2421509T3 (en) 2018-02-26
CN102438593A (zh) 2012-05-02
US20120165410A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
IL254370A0 (he) ייצור של נאנו–חלקיקים מצופים בנפח חלקיקים גבוה
AP3776A (en) Production of encapsulated nanoparticles at commercial scale
GB0901857D0 (en) Encapsulated nanoparticles
EP2614177A4 (en) PHOTOACTIVE MATERIAL COMPRISING NANOPARTICLES OF AT LEAST TWO PHOTOACTIVE COMPONENTS
EP2435577A4 (en) GLYCOPROTEIN PRODUCTION
EP2507397A4 (en) CLASSIFICATION OF CANCERS
ZA201301752B (en) Improved production of prtein solutions from soy
GB0905488D0 (en) Organopolysiloxane compositions and their production
IL216857A0 (en) Production of algae
GB201004096D0 (en) Production of polyhydroalkanoates
ZA201202509B (en) Production of hydrocarbons
EP2459608A4 (en) POLYMER ENCAPSULATION OF PARTICLES
GB201014977D0 (en) Fluorescent gold nanoparticles
GB0910401D0 (en) Production of nanoparticles
GB201011628D0 (en) Production of nanoparticles
AU2009901744A0 (en) Production of Encapsulated Nanoparticles at High Volume Fractions
GB2463291B (en) Production of hydroelectricity
AU2009901740A0 (en) Production of Encapsulated nanoparticles at Commercial Scale
GB0801977D0 (en) Production of l-iduronate containing polysaccharides
IL200359A0 (en) Particle separtation
GB201015060D0 (en) Production of nanoparticles
GB201013861D0 (en) Production of nanoparticles
GB0914632D0 (en) Production of flake particles
HK1159244A (en) Encapsulated nanoparticles
GB0920364D0 (en) Production of artemisinin